Vishwas Setia - 27 Jan 2026 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Role: Chief Financial Officer
Signature: /s/ Kristopher L. Hanson, Attorney-in-Fact
Issuer symbol: MPLT
Transactions as of: 27 Jan 2026
Net transactions value: -$600,208
Form type: 4
Filing time: 29 Jan 2026, 16:30:20 UTC
Previous filing: 28 Oct 2025
Next filing: 09 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Setia Vishwas	Chief Financial Officer	C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY	/s/ Kristopher L. Hanson, Attorney-in-Fact	29 Jan 2026	0002021256

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MPLT	Voting Common Stock	Tax liability	$600,208	-33,382	-7.9%	$17.98	387,819	27 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of a restricted stock unit award. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.

Content

Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of a restricted stock unit award. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025.